Reuters logo
BRIEF-uniQure announces it will not seek marketing authorization renewal for Glybera in Europe
April 20, 2017 / 11:37 AM / 7 months ago

BRIEF-uniQure announces it will not seek marketing authorization renewal for Glybera in Europe

April 20 (Reuters) - uniQure NV

* uniQure announces it will not seek marketing authorization renewal for Glybera in Europe

* Marketing authorization for Glybera® to expire on October 25, 2017

* Maintains focus on core programs in Hemophilia B, Huntington’s Disease and congestive heart failure

* Will continue to make product available to chiesi to treat any patients that are approved for treatment prior to October 25, 2017

* Expects to reduce future expenses related to product by about $2 million annually, beginning in 2018 and net of any payments to Chiesi Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below